Europe's CISPE challenges Broadcom's $69 billion VMware deal in EU court

European cloud providers' group CISPE has filed a formal appeal with the European General Court, seeking to annul the European Commission's approval of Broadcom's $69 billion acquisition of VMware. CISPE alleges the EC failed to impose sufficient conditions despite acknowledging competition risks, citing Broadcom's subsequent unfair software licensing practices that are impacting European cloud users. This challenge could subject the major tech deal to judicial review, with both Broadcom and the Commission prepared to defend their original approval.

Analysis

Broadcom's $69 billion acquisition of VMware, which closed in November 2023, is now facing a significant post-merger legal challenge in the European Union. The cloud provider association CISPE has appealed to the European General Court to annul the European Commission's approval of the deal. The core of the complaint is that the Commission acknowledged significant competition risks but failed to impose adequate remedies, particularly concerning Broadcom's software licensing practices. CISPE alleges that Broadcom has since implemented 'unfair new licensing terms' that negatively impact a wide swath of European organizations, leveraging VMware's dominant position in the virtualization market. This legal action introduces a new layer of regulatory uncertainty and headline risk for Broadcom (AVGO), as both the company and the European Commission must now defend the approval in court. The challenge directly targets the post-acquisition monetization strategy, a key element in Broadcom's plan to boost its software business through the VMware integration.

Key Decisions for Investors

• Investors in Broadcom (AVGO) should closely monitor the proceedings at the European General Court, as an adverse ruling could challenge the strategic and financial assumptions behind the VMware acquisition.
• It is crucial to scrutinize future earnings calls for any commentary on VMware's customer retention, licensing revenue trends in Europe, and potential adjustments to synergy forecasts stemming from this legal challenge.
• Given the moderately negative sentiment and the introduction of significant legal uncertainty, investors should be prepared for increased headline risk and potential stock price volatility for AVGO until the matter is resolved.